CTRI/2022/03/041485尚未招募4 期
Efficacy of homoeopathic medicine in the management of irritable bowel syndrome by using synthesis-repertorium homeopathicum syntheticum 9.1 repertory and to assess the quality of life
Vinayaka Missions Homoeopathic Medical College and Hospital1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2022年11月4日最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- Based on the Rome III criteria, clinical symptoms of irritable bowel syndrome are assessed
研究概览
简要总结
| Irritable Bowel Syndrome is one of the main psychosomatic disorders characterized by recurrent abdominal pain in abdomen, abdominal swelling, diarrhoea, constipation, eructation and flatulence and mucorrhea. In developed countries, its mainly seen in 10 – 15% adults. In India, IBS is seen in almost 4.2 % of the population. In Males the estimate is 4.3% and in females it is 4.0%.Younger people have higher prevalence of irritable bowel syndrome in the population. IBS is psychosomatic in origin and a result of modern life style and presents with lot of clinical symptoms. Experience says that Homoeopathy stands out for its Holistic approach towards diseases. Repertory stands greater height as best approach for any type of cases. Synthesis 9.1 is a very such tool which fulfils the requirement of ailments from, mental generals, physical generals and clinical symptoms., which I am using to find out the similimum. This study is the small attempt to highlight the efficacy of homeopathic similimum achieved by using Synthesis 9.1 repertory in treatment of Irritable Bowel Syndrome. |
研究设计
- 研究类型
- Interventional
- 分配方式
- Other
- 盲法
- Participant Blinded
入排标准
- 年龄范围
- 10.00 Year(s) 至 65.00 Year(s)（—）
- 性别
- All
入选标准
- •All cases that fit into the ROME III diagnostic criteria, The patients of all age groups and both sexes, Patients who are pre diagnosed with IBS, Patients irrespective of ethnic groups socio economic status and occupation will be considered.
排除标准
- •Cases which does not fit Rome III criteria Cases which have other systemic illness.
- •Cases with symptoms for less than 3 months.
结局指标
主要结局
Based on the Rome III criteria, clinical symptoms of irritable bowel syndrome are assessed
时间窗: At baseline and after 6 months
次要结局
- it is expected that the proposed study will be useful in reducing the symptoms of irritable bowel syndrome and to improve the quality of life of the patients(At baseline And after 6 months)
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
2 期
Treatment of irritable bowel syndrome by homoeopathyCTRI/2025/06/088181The Calcutta Homoeopathic Medical College and Hospital93
招募中
3 期
Homoeopathy in the management of irritable bowel syndrome.CTRI/2023/12/060858Central Council for Research in Homoeopathy90
尚未招募
不适用
Stress As A Reactive Pattern To Irritable Bowel SyndromeCTRI/2019/12/022275Bakson Homoeopathic Medical College and Hospital44
终止
3 期
Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) With LACTEOL® 340 mgDiarrhea-predominant Irritable Bowel SyndromeNCT01358708Forest Laboratories26
终止
不适用
Irritable Bowel Syndrome and Osteopathic Manipulative TherapyIrritable Bowel SyndromeNCT02932111Assistance Publique - Hôpitaux de Paris157